Favorites Sign in

One plan - full access

No subscription, no auto-renewal, no hidden terms.
Pay once and use it for 30 days.

PRO plan No auto-renewal
$18

30 days of full access
One-time payment

🌐 US & Global Companies
Get access for 30 days →
♧ Secure payment · Instant access

What is included

  • ✓Full access to detailed company analysis
  • ✓Fundamental screener
  • ✓Advanced stock screener filters
  • ✓5 ratings. Separate lists for US & Global Companies and MOEX
  • ✓Company data export in XLSX and CSV
  • ✓MarketCap’s overall ranking of top companies
  • ✓Analytics updates after each new financial report
⚠ The service is not an investment advisor. Financial statement data from public companies is available to everyone - MarketCap structures and analyzes it.
  1. Home
  2. Companies
  3. Inter Parfums
  4. Financial Ratios
Inter Parfums logo
Inter Parfums IPAR
$ 135.62 -1.14%
report update icon

Quarterly report 2026-Q3
added 11-04-2026

Inter Parfums Financial Ratios 2025-2008 | IPAR

Brief overview of Inter Parfums's valuation and returns

The review covers five available annual periods spanning 2021 to 2025.

The current valuation set is P/E 17.92x (median 31.89x), EV/EBITDA 19.26x (median 18.65x), P/S 2.03x (median 3.55x). Multiples are on average 42.9% below their own medians. Shares look cheaper than their recent historical valuation.

The 1/P/E calculation produces a 5.6% earnings yield. It does not capture future growth or capital structure.

The latest available business-quality ratios are ROE 19.1%, ROA 10.6%, ROCE 30.7%. Business quality is high on return ratios, supporting the ability to create value.

PEG is 0.53x. Price is low relative to embedded growth, though the ratio depends heavily on forecast quality.

The time from paying for inputs to receiving cash rose from 194.7 days to 260.1 days. Cash turnover slowed.

Conclusion

Inter Parfums's fundamental efficiency looks stronger than its current valuation relative to history. Future reports should confirm the conclusion.

Annual Financial Ratios Inter Parfums

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008

P/E

 14.5 14.8 26.2 25.5 28.5 51.0 36.7 38.6 35.8 30.3 27.3 26.4 25.7 5.1 16.0 17.3 12.2 -

P/S

 2.0 2.1 3.7 3.5 3.6 3.6 3.1 3.1 2.5 1.9 1.8 1.6 1.8 1.0 0.8 1.0 - -

EPS

 5.2 5.1 4.8 3.8 2.8 1.2 1.9 1.7 1.3 1.1 1.0 0.9 1.3 4.3 1.1 0.9 0.7 -

EV (Enterprise Value)

 3.02 B 3.01 B 4.93 B 3.86 B -156 B 1.78 B 2.29 B 2.1 B 1.49 B 1.05 B 867 M 794 M 1.01 B 620 M 672 M 423 M 172 M -42.4 M

EBITDA per Share

 9.21 9.46 8.4 6.81 5.07 2.51 3.61 3.38 2.97 2.67 2.27 2.06 2.92 3.17 2.65 1.97 1.85 -

EV/EBITDA

 10.2 9.9 18.3 17.8 -973.4 22.5 18.4 18.6 14.2 10.9 10.4 10.8 9.9 4.0 5.9 7.1 3.1 -

PEG

 0.43 0.52 0.96 1.01 1.38 13.34 3.15 1.33 1.47 3.28 8.59 -1.04 -0.37 0.02 0.78 - - -

P/B

 1.9 2.1 3.6 2.9 2.7 2.2 3.6 3.5 2.6 2.1 1.7 1.6 1.9 1.3 1.6 1.1 - -

P/CF

 14.0 16.1 46.6 52.8 26.2 30.0 34.0 41.0 46.8 20.7 -11.3 24.0 27.7 21.2 -13.5 12.2 3.2 -

ROE %

 23.62 27.25 26.88 24.48 19.23 7.13 9.89 9.18 7.29 6.89 6.39 5.90 7.32 26.23 9.96 11.32 7.78 -

ROA %

 13.12 14.38 13.73 11.54 9.60 4.29 7.27 6.73 5.35 4.88 4.43 4.87 5.90 17.26 6.26 6.07 - -

ROCE %

 30.69 36.89 35.94 31.50 25.89 13.08 16.25 15.47 13.22 12.53 11.00 10.66 14.64 16.16 20.51 24.02 15.59 -

Current Ratio

 - - - - - - 3.1 3.0 3.3 3.4 3.6 4.7 4.2 2.4 2.1 - - -

DSO

 73.0 65.6 61.6 59.9 58.8 87.0 69.2 75.3 78.2 79.1 76.0 67.7 57.5 85.8 106.7 38.7 - -

DIO

 243.9 258.6 252.4 227.5 202.4 286.2 228.9 236.9 232.7 181.9 200.5 176.0 182.4 210.8 262.2 - - -

DPO

 56.7 65.5 70.8 79.3 66.5 78.6 73.8 85.8 89.3 92.9 103.2 80.2 88.2 108.1 180.1 - - -

Operating Cycle

 316.9 324.1 314.0 287.4 261.2 373.2 298.1 312.2 310.9 261.0 276.5 243.7 239.9 296.6 368.9 38.7 - -

Cash Conversion Cycle

 260.1 258.6 243.1 208.1 194.7 294.7 224.3 226.4 221.6 168.1 173.3 163.5 151.7 188.6 188.8 38.7 - -

All numbers in USD currency

Quarterly Financial Ratios Inter Parfums

2026-Q3 2026-Q2 2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

 2.13 0.95 1.35 0.8799999999999999 2.05 1 1.32 0.7599999999999998 1.94 1.15 1.28 0.3299999999999992 1.66 1.09 1.69 0.52 1.3 0.87 1.11 -0.040000000000000036 1.21 0.72 0.87 0.47 0.52 -0.1 0.32 0.26 0.66 0.39 0.6 0.26 0.6 0.35 0.51 0.14000000000000012 0.55 0.22 0.43 0.1200000000000001 0.52 0.19 0.24 0.05999999999999994 0.46 0.14 0.32 0.10999999999999999 0.36 0.2 0.29 -0.1399999999999999 0.26 0.12 1.03 3.26 0.33 0.2 0.51 0.14 0.34 0.16 0.42

EBITDA per Share

 3.87 1.71 2.5 -2.74 K 3.58 2.04 2.52 4.67 K 3.5 2.21 2.31 0.43 - - 2.95 K 0.73 2.02 K 1.43 K 1.92 K -0.39 2.14 K 1.41 K 1.52 K 0.84 994 -175 0.56 1.74 K 1.17 0.71 1.06 K - 1.12 0.6 0.97 0.15 1.06 0.46 0.84 0.13 1.12 0.45 0.64 1.12 K 0.94 0.29 0.75 772 0.69 0.5 0.65 -0.62 0.56 0.33 2.3 15.1 0.85 0.54 1.16 0.3 0.82 0.56 0.94

ROE %

 19.04 18.58 19.10 19.50 19.77 20.03 21.30 21.67 19.76 19.50 19.35 21.83 23.05 22.81 22.57 20.33 17.44 16.70 15.91 14.99 18.27 15.04 10.56 7.59 6.50 7.66 10.77 12.76 12.87 12.53 12.40 11.85 11.29 11.07 10.32 10.28 10.22 10.52 10.37 8.65 8.02 7.60 7.18 8.18 8.62 7.49 7.75 7.09 5.14 4.26 3.70 9.64 38.03 39.90 40.46 38.03 12.65 12.98 13.45 12.75 3.99 1.89 5.05

ROA %

 13.53 13.26 13.42 13.59 13.70 13.57 14.34 14.45 13.16 12.71 12.44 13.67 14.36 14.41 14.40 13.20 11.43 11.06 10.55 9.76 12.24 10.49 7.48 5.98 5.05 5.70 8.01 9.34 9.42 9.21 9.12 8.81 8.40 8.17 7.60 7.47 7.40 7.55 7.43 6.18 5.72 5.36 5.04 6.07 6.47 6.01 6.39 5.90 4.31 3.58 3.09 6.88 25.74 26.90 27.76 25.99 9.24 9.13 8.84 7.44 2.54 1.28 2.47

ROCE %

 22.28 22.78 24.31 25.10 26.70 27.63 29.22 29.26 27.56 26.74 26.04 29.18 30.01 28.90 28.68 26.13 21.53 21.60 21.46 20.17 25.60 21.48 14.43 10.60 8.86 10.25 14.93 17.56 17.35 17.11 16.61 16.09 15.13 15.08 14.53 14.66 14.93 15.40 15.02 13.32 13.10 12.39 11.79 12.86 12.86 10.85 11.49 10.11 7.21 6.23 5.35 14.90 59.30 62.79 63.68 59.95 20.33 20.66 21.45 22.55 6.48 3.19 10.11

Current Ratio

 3.3 3.7 - 3.3 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DSO

 71.9 84.9 86.4 80.8 70.1 81.8 77.7 79.4 70.2 79.0 76.1 74.3 65.0 70.6 64.3 61.3 67.1 74.3 66.5 76.5 64.3 71.8 63.0 65.1 61.3 194.5 84.0 78.7 76.8 86.5 77.0 76.7 78.4 93.5 76.2 85.5 75.0 91.6 78.0 - 71.4 81.2 82.9 - 72.2 83.1 77.9 - 74.2 75.9 67.6 - 86.6 122.1 72.5 - 84.1 95.1 93.6 - 76.0 110.6 -

DIO

 242.7 289.3 273.6 226.7 236.8 332.0 285.2 278.7 251.7 313.2 289.7 289.5 248.5 258.1 257.4 236.2 254.2 247.3 211.2 205.4 153.0 189.3 191.5 232.0 268.8 733.5 275.9 242.1 206.3 265.9 218.2 245.4 221.7 263.8 192.0 244.1 187.3 250.6 - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

 52.9 65.3 61.7 44.2 46.6 77.6 70.5 66.6 61.0 80.7 76.4 72.6 61.1 69.5 76.1 70.0 76.3 78.2 76.6 74.6 51.2 63.5 50.0 43.2 44.0 161.6 82.2 71.2 55.6 86.2 80.9 80.3 76.1 106.0 76.8 96.3 84.2 128.9 - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

 314.6 374.2 360.0 307.6 306.9 413.8 362.9 358.1 321.9 392.2 365.8 363.8 313.6 328.8 321.8 297.6 321.3 321.6 277.8 281.9 217.3 261.1 254.4 297.1 330.1 927.9 359.9 320.8 283.0 352.4 295.2 322.1 300.1 357.3 268.2 329.6 262.3 342.2 78.0 - 71.4 81.2 82.9 - 72.2 83.1 77.9 - 74.2 75.9 67.6 - 86.6 122.1 72.5 - 84.1 95.1 93.6 - 76.0 110.6 -

Cash Conversion Cycle

 261.7 308.9 298.3 263.4 260.3 336.1 292.3 291.4 260.9 311.6 289.4 291.2 252.4 259.2 245.7 227.6 245.0 243.4 201.1 207.3 166.2 197.6 204.5 253.9 286.0 766.4 277.7 249.6 227.5 266.2 214.3 241.8 224.1 251.3 191.4 233.3 178.1 213.3 78.0 - 71.4 81.2 82.9 - 72.2 83.1 77.9 - 74.2 75.9 67.6 - 86.6 122.1 72.5 - 84.1 95.1 93.6 - 76.0 110.6 -

All numbers in USD currency

Multiples are an important financial analysis tool for the company Inter Parfums, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.

Advantages of Using Financial Ratios
  • Simplified Data Analysis
    Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition.
  • Comparability Between Companies
    Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations.
  • Identification of Trends and Issues
    Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks.
  • Decision Support
    Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions.
  • Accelerated Assessment of Investment Attractiveness
    Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.

Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.

Financial Ratios of other stocks in the Household products industry

Issuer Price % 24h Market Cap Country
The Clorox Company The Clorox Company
CLX
 		$ 106.6 1.01 % $ 12.9 B usaUSA
The Estée Lauder Companies The Estée Lauder Companies
EL
 		$ 113.35 0.17 % $ 41.1 B usaUSA
Unilever PLC Unilever PLC
UL
 		$ 66.48 -0.2 % $ 145 B britainBritain
Colgate-Palmolive Company Colgate-Palmolive Company
CL
 		$ 98.06 0.12 % $ 79.3 B usaUSA
The Procter & Gamble Company The Procter & Gamble Company
PG
 		$ 168.81 0.29 % $ 394 B usaUSA
United-Guardian United-Guardian
UG
 		$ 9.01 1.81 % $ 41.4 M usaUSA
USANA Health Sciences USANA Health Sciences
USNA
 		$ 13.1 -5.42 % $ 243 M usaUSA
Revlon Revlon
REV
 		- -4.41 % $ 212 M usaUSA
Church & Dwight Co. Church & Dwight Co.
CHD
 		$ 111.77 0.41 % $ 27.1 B usaUSA
Kimberly-Clark Corporation Kimberly-Clark Corporation
KMB
 		$ 110.78 -1.03 % $ 36.8 B usaUSA
Hims & Hers Health Hims & Hers Health
HIMS
 		$ 19.1 -16.76 % $ 4.3 B usaUSA
Coty Coty
COTY
 		$ 4.34 2.73 % $ 3.81 B usaUSA
e.l.f. Beauty e.l.f. Beauty
ELF
 		$ 118.5 -0.71 % $ 6.9 B usaUSA
Dogness (International) Corporation Dogness (International) Corporation
DOGZ
 		$ 0.44 -1.36 % $ 7.84 M chinaChina
Helen of Troy Limited Helen of Troy Limited
HELE
 		$ 38.19 2.28 % $ 878 M bermudaBermuda
Newell Brands Newell Brands
NWL
 		$ 5.94 0.76 % $ 2.48 B usaUSA
Acme United Corporation Acme United Corporation
ACU
 		$ 70.35 1.6 % $ 266 M usaUSA
Edgewell Personal Care Company Edgewell Personal Care Company
EPC
 		$ 29.61 0.25 % $ 1.41 B usaUSA
LifeVantage Corporation LifeVantage Corporation
LFVN
 		$ 4.64 -12.29 % $ 58.2 M usaUSA
Mannatech, Incorporated Mannatech, Incorporated
MTEX
 		$ 8.62 -3.69 % $ 16.4 M usaUSA
Nature's Sunshine Products Nature's Sunshine Products
NATR
 		$ 10.89 -1.23 % $ 196 M usaUSA
Nu Skin Enterprises Nu Skin Enterprises
NUS
 		$ 4.04 -5.61 % $ 199 M usaUSA
Natura &Co Holding S.A. Natura &Co Holding S.A.
NTCO
 		- - $ 9.02 B -
Spectrum Brands Holdings Spectrum Brands Holdings
SPB
 		$ 88.66 -0.75 % $ 2.28 B usaUSA